G-protein beta-3-subunit and eNOS gene polymorphism in transplant recipients with long-term renal graft function

Kidney and Blood Pressure Research

Volumn 25, Issue 4, 2002, Pages 245-249

  Viklický, Ondřej ^a   Hubáček, Jaroslav A ^a   Vítko, Štefan ^a   Heemann, Uwe W ^b   Vasarhelyi, Barna ^c   Kohnle, Mathias ^b   Teplan, Vladimír ^a   Lácha, Jiří ^a   Szabó, Attila J ^c  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Endothelial nitric oxide synthase; G protein; Gene polymorphism; Kidney transplantation; Long term graft survival

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; CYCLOSPORIN A; ENDOTHELIAL NITRIC OXIDE SYNTHASE; G PROTEIN BETA 3 SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; G PROTEIN BETA3 SUBUNIT; G-PROTEIN BETA3 SUBUNIT; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, HUMAN;

ACUTE GRAFT REJECTION; ADULT; AGED; ALLELE; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SUBSTITUTION; FEMALE; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOTYPE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY GRAFT; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECIPIENT; RISK FACTOR; ARTERIOSCLEROSIS; CLINICAL TRIAL; GENETICS; KIDNEY FUNCTION TEST; KIDNEY TRANSPLANTATION; MIDDLE AGED; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALLELES; ARTERIOSCLEROSIS; BODY MASS INDEX; FEMALE; GENOTYPE; GRAFT SURVIVAL; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS;

EID: 19044383568     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066346     Document Type: Article

References (26)

1. Tullius SG, Tilney NL: Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 1995;59:313-318.
2. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R, Sharma AM, Ritz E, Wichmann HE, Jakobs KH, Horsthemke B: Associaton of a human G-protein beta3 subunit variant with hypertension. Nat Genet 1998;1:45-48.
3. Beige J, Hohenbleicher H, Distler A, Sharma AM: G-protein beta 3 subunit C825T variant and ambulatory blood pressure in essential hypertension. Hypertension 1999;33:1049-1051.
4. Bluthner M, Schmidt S, Siffert W, Knigge H, Nawroth P, Ritz E: Increased frequency of G-protein β3-subunit 825 T allele in dialyzed patients with type 2 diabetes. Kidney Int 1999;55:1247-1250.
5. Miyamoto Y, Saito Y, Kajiyama N, Yoshimura M, Shimasaki Y, Nakayama M, Kamitani S, Harada M, Ishikawa M, Kuwahara K, Ogawa E, Hamanaka I, Takahashi N, Kaneshige T, Teraoka H, Akamizu T, Azuma N, Yoshimasa Y, Yoshimasa T, Itoh H, Masuda I, Yasue H, Nakao K: Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 1998;32:3-8.
6. Zanchi I, Moczulski DK, Hanna LS, Wantman M, Warram JH, Krolewski AS: Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int 2000;57:405-413.
7. Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A, Haydock S, Hopper RV, Stephens NG, O'Shaughnessy KM, Brown MJ: A common variant of the endothelial nitric oxide synthase (Glu(298)Asp) is a major risk factor for coronary artery disease in the UK. Circulation 1999;100:1515-1520.
8. Siffert W, Forster P, Jockel KH, Mvere DA, Brinkmann B, Naber C, Crookes R, Du P Heyns A, Epplen JT, Fridey J, Freedman BI, Muller N, Stolke D, Sharma AM, Al Mountaery K, Grosse-Wilde H, Buerbaum B, Ehrlich T, Ahmad HR, Horsthemke B, Du Toit ED, Tiilikainen A, Ge J, Wang Y, Rosskopf D: Worldwide ethnic distribution of the G protein beta 3 subunit 825T allele and its association with obesity in Caucasia, Chinese, and Black African individuals. J Am Soc Nephrol 1999;10:1921-1930.
9. Poch E, Gonzalez D, Gomez-Angelats E, Enjuto M, Pare JC, Rivera F, de La Sierra A: G-Protein beta (3) subunit gene variant and left ventricular hypertrophy in essential hypertension. Hypertension 2000;35:214-218.
10. Morrison AC, Doris PA, Folsom AR, Nieto C, Boerwinkle E: G-protein β3 subunit and α-adducin polymorphisms and risk of subclinical and clinical stroke. Stroke 2001;32:822-829.
11. Blüther M, Schmidt S, Siffert W, Knigge H, Nawroth P, Ritz E: Increased frequency of G-protein beta 3-subunit 825T allele in dialysed patients with type 2 diabetes. Kidney Int 1999;55:1247-1250.
12. Wuthrich RP, Cicvara S, Booy C, Widmer U, Binswanger U: The 825C/T polymorphism of the G-protein subunit beta3 does not influence blood pressure and renal function in kidney transplant recipients. Nephrol Dial Transplant 2000;15:1663-1666.
13. Beige J, Engeli S, Ringel J, Offermann G, Distler A, Sharma AM: Donor G protein beta3 subunit 825TT genotype is associated with reduced kidney allograft survival. J Am Soc Nephrol 1999;10:1717-1721.
14. Schunkert H, Hense HW, Doring A, Riegger GAJ, Siffert W: Association between a polymorphism in the G protein β3 subunit gene and lower renin and elevated diastolic blood pressure. Hypertension 1998;32:510-513.
15. Zeier M, Mandelbaum A, Ritz E: Hypertension in the transplanted patient. Nephron 1998;80:257-268.
16. Naber CK, Hüsing J, Wolfhard U, Erbel R, Siffert W: Interaction of the ACE D allele and the GNB3 825T allele in myocardial infarction. Hypertension 2000;36:986-989.
17. Fernandez-Llama P, Poch E, Oriola J, Botey A, Coll E, Darnell A, Rivera F, Revert L: Angiotensin converting enzyme gene I/D polymorphism in essential hypertension and nephroangiosclerosis. Kidney Int 1998;53:1743-1747.
18. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-644.
19. Viklicky O, Hubacek JA, Pitha J, Teplan V, Heemann UW, Lacha J, Vitko S: ACE gene polymorphism and long-term renal graft function. Clin Biochem 2001;54:87-90.
20. Meier-Kriesche HU, Vaghela M, Thambuganipalle R, Friedman G, Jacobs M, Kaplan B: The effect of body mass index on long-term renal allograft survival. Transplantation 1999;68:1294-1297.
21. Orofino L, Pascual J, Quereda C, Burgos J, Marcen R, Ortuno J: Influence of overweight on survival of kidney transplant. Nephrol Dial Transplant 1997;12:855.
22. Shimasaki Y, Yasue H, Yoshimura M, Nakayama M, Kugiyama K, Ogawa H, Harada E, Masuda T, Koyama W, Saito Y, Miyamoto Y, Ogawa Y, Nakao K: Association of the missence Glu298Asp variant of the endothelium nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 1998;31:1506-1510.
23. Kato N, Sugiyama T, Morita H, Nabika T, Kurihara H, Yamori Y, Yazaki Y: Lack of evidence for association between the endothelial nitric oxide synthase gene and hypertension. Hypertension 1999;33:933-936.
24. Lee PC, Wang ZL, Qian S, Watkins SC, Lizonova A, Kovesdi I, Tzeng E, Simmons RL, Billiar TR, Shears LL: Endothelial nitric oxide synthase protects aortic allografts from the development of transplant arteriosclerosis. Transplantation 2000;69:1186-1192.
25. Iwata A, Sai S, Moore M, Nyhuis J, de Fries-Hallstrand R, Quentingco GC, Allen MD: Gene therapy of transplant arteriopathy by liposome-mediated transfection of endothelial nitric oxide synthase. J Heart Lung Transplant 2000;19:1017-1028.
26. Jachymova M, Horky K, Butlas J, Kozich V, Jindra A, Peleska J, Martasek P: Association of the Glu298Asp polymorphism in the endothelial nitric oxide synthase gene with essential hypertension resistant to conventional therapy. Biochem Biophys Res Commun 2001;284:426-430.